Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies
Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...
Evan Seigerman’s Buy Rating on Amgen Driven by Positive MariTide Outlook and Undervaluation
BMO Capital analyst Evan Seigerman has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...
Investing in Pharma Stocks? Check These 3 Things First
The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...
This Single Lifestyle Factor Can Reduce Your Risk for Stroke, Heart Attack, Diabetes, and More
Lowering BMI alone may reduce the risk of various obesity-related diseases, but other factors might also play a role. A new ...
TCTMD3d
Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III
In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?
BioPharma Dive3d
Amgen picks prolific biotech founder Chang as new top scientist
Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...
STAT3d
Pharmalittle: We’re reading about Trump and tariff worries, PBM rules in New York, and more
Some industry leaders are confident health care products such as drugs will be carved out of expected Trump administration tariffs ...
BioSpace3d
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
devdiscourse3d
Global Health Updates: Innovations and Challenges in Fighting Diseases
Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...
Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
Wall Street awaits Amgen weight-loss drug data expected to move shares
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
Amgen Names Howard Chang as Chief Scientific Officer
Amgen on Wednesday said Howard Chang will join the company as senior vice president of research, effective Dec. 16. The company said Chang, who will also serve as chief scientific officer, will ...